Danco Laboratories, L.L.C. v. Alliance for Hippocratic Medicine
Consolidated with:
| Docket No. | Op. Below | Argument | Opinion | Vote | Author | Term |
|---|---|---|---|---|---|---|
| 23-236 | 5th Cir. | Mar 26, 2024 | Jun 13, 2024 | 9-0 | Kavanaugh | OT 2023 |
Holding: Plaintiffs lack Article III standing to challenge the Food and Drug Administration's regulatory actions regarding mifepristone.
Judgment: Reversed and remanded, 9-0, in an opinion by Justice Kavanaugh on June 13, 2024. Justice Thomas filed a concurring opinion.
SCOTUSblog Coverage
- Supreme Court appears likely to allow abortion drug to remain available (Amy Howe, March 26, 2024)
- A fast-moving argument over medication abortion (Mark Walsh, March 26, 2024)
- Abortion access again before Supreme Court (Amy Howe, March 25, 2024)
- Court schedules abortion pill case for March argument session (Amy Howe, January 29, 2024)
- Justices will review lower-court ruling on access to abortion pill (Amy Howe, December 13, 2023)
- Court to weigh in on scope of law used in Jan. 6 prosecutions (Amy Howe, December 13, 2023)
- Federal government and drug manufacturer ask court to review ruling restricting access to abortion medication (Amy Howe, September 10, 2023)
| Date | Proceedings and Orders |
|---|---|
| 09/08/2023 | Petition for a writ of certiorari filed. (Response due October 12, 2023) |
| 09/29/2023 | Motion to extend the time to file a response from October 12, 2023 to November 9, 2023, submitted to The Clerk. |
| 09/29/2023 | Application (23A301) to file consolidated brief in opposition in excess of word limits, submitted to Justice Alito. |
| 10/02/2023 | Motion to extend the time to file a response is granted and the time is extended to and including November 9, 2023. |
| 10/07/2023 | Application (23A301) to file consolidated brief in opposition in excess of word limits granted by Justice Alito. The consolidated brief in opposition may not exceed 13,500 words. |
| 10/12/2023 | Brief amici curiae of Over 600 State Legislators filed. VIDED. |
| 10/12/2023 | Brief amici curiae of American College of Obstetricians and Gynecologists, et al. filed. VIDED. |
| 10/12/2023 | Brief amici curiae of Food and Drug Law Scholars filed. VIDED. |
| 10/12/2023 | Brief amici curiae of Pharmaceutical Companies, Executives, and Investors filed. VIDED. |
| 10/12/2023 | Brief amici curiae of Patient and Provider Advocacy Organizations filed. VIDED. |
| 10/12/2023 | Brief amici curiae of National Association of Nurse Practitioners in Women's Health, et al. filed. VIDED. |
| 10/12/2023 | Brief amicus curiae of GenBioPro, Inc. filed. VIDED. |
| 10/12/2023 | Brief amici curiae of Local Governments and Local Government Leaders filed. VIDED. |
| 10/12/2023 | Brief amici curiae of The City of New York, et al. filed. VIDED. |
| 10/12/2023 | Brief amici curiae of 257 Members of Congress filed. VIDED. |
| 10/12/2023 | Brief amici curiae of New York, et al. filed. VIDED. |
| 10/12/2023 | Brief amici curiae of Doctors for America and the Reproductive Health Coalition filed. VIDED. |
| 10/12/2023 | Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed. VIDED. |
| 10/12/2023 | Brief amici curiae of Religious Coalition for Reproductive Choice, et al. filed.(10/26/23) VIDED. |
| 11/09/2023 | Brief of respondents Alliance for Hippocratic Medicine, et al. in opposition filed. VIDED. |
| 11/15/2023 | Waiver of the 14-day waiting period for the distribution of the petition pursuant to Rule 15.5 filed by petitioner. |
| 11/21/2023 | DISTRIBUTED for Conference of 12/8/2023. |
| 11/21/2023 | Reply of petitioner Danco Laboratories, L.L.C. filed. (Distributed) |
| 12/13/2023 | Petition GRANTED. The petition for a writ of certiorari in No. 23-235 is granted. The cases are consolidated, and a total of one hour is allotted for oral argument. |
| 12/13/2023 | Because the Court has consolidated these cases for briefing and oral argument, future filings and activity in the cases will now be reflected on the docket of No. 23-235. Subsequent filings in these cases must therefore be submitted through the electronic filing system in No. 23-235. Each document submitted in connection with one or more of these cases must include on its cover the case number and caption for each case in which the filing is intended to be submitted. Where a filing is submitted in fewer than all of the cases, the docket entry will reflect the case number(s) in which the filing is submitted; a document filed in all of the consolidated cases will be noted as “VIDED.” |
| 01/29/2024 | SET FOR ARGUMENT on Tuesday, March 26, 2024. VIDED. |
| 01/31/2024 | Record requested from the United States Court of Appeals for the Fifth Circuit. |
| 02/09/2024 | Sealed record received electronically from the United States District Court for the Northern District of Texas and available with the Clerk. |
| 02/13/2024 | Public electronic record on appeal received from the United States District Court for the Northern District of Texas (one DVD) and available with the Clerk. |
| 02/13/2024 | Record received from the United States Court of Appeals for the Fifth Circuit. The record is electronic and is available on PACER. |
| 02/14/2024 | CIRCULATED |
| 03/26/2024 | Argued. For federal petitioners: Elizabeth B. Prelogar, Solicitor General, Department of Justice, Washington, D. C. For petitioner Danco Laboratories, L.L.C.: Jessica L. Ellsworth, Washington, D. C. For respondents: Erin M. Hawley, Washington, D. C. VIDED. |
| 06/13/2024 | Judgment REVERSED and case REMANDED. Kavanaugh, J., delivered the opinion for a unanimous Court. Thomas, J., filed a concurring opinion. VIDED. |
| 07/15/2024 | Judgment Issued. |
| 08/22/2024 | Record returned to the United States District Court for the Northern District of Texas. |